NCT00550797 - Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

October 31, 2008

Conditions

Allergic Asthma

Interventions

BIOLOGICAL

TPI ASM8

Administered with the I-Neb device from Respironics once daily by inhalation over 2 treatment periods of 14 days each

BIOLOGICAL

placebo

Administered with the I-Neb device from Respironics once daily by inhalation over 2 treatment periods of 14 days each

Trial Locations (1)

King's College inLondon, London